Yoshihiko Hirohashi

Survivin Expression Is Regulated by Coexpression of Human Epidermal Growth Factor Receptor 2 and Epidermal Growth Factor Receptor via Phosphatidylinositol 3-Kinase/AKT Signaling Pathway in Breast Cancer Cells

Hiroko Asanuma, Toshihiko Torigoe, Kenjiro Kamiguchi et al. · Cancer Research · 2005 · 199 citations · Full text

Life Sciences, Cell Biology, Oncology +17

An HLA-A24-restricted cytotoxic T lymphocyte epitope of a tumor-associated protein, survivin.

Yoshihiko Hirohashi, Toshihiko Torigoe, Akiko Maeda et al. · PubMed · 2002 · 188 citations

Life Sciences, Immunology, Oncology +14

Phase I clinical study of anti-apoptosis protein, survivin-derived peptide vaccine therapy for patients with advanced or recurrent colorectal cancer

Tetsuhiro Tsuruma, Fumitake Hata, Toshihiko Torigoe et al. · Journal of Translational Medicine · 2004 · 181 citations · Full text

Medicine, Immunology, Oncology +17

SOX2 is overexpressed in stem-like cells of human lung adenocarcinoma and augments the tumorigenicity

Munehide Nakatsugawa, Akari Takahashi, Yoshihiko Hirohashi et al. · Laboratory Investigation · 2011 · 126 citations · Full text

Medicine, Molecular Biology, Oncology +12

A Potent Immunogenic General Cancer Vaccine That Targets Survivin, an Inhibitor of Apoptosis Proteins

Satomi Idenoue, Yoshihiko Hirohashi, Toshihiko Torigoe et al. · Clinical Cancer Research · 2005 · 121 citations · Full text

Life Sciences, Immunology, Oncology +17